Yun-Juan Bao

Dr. Yun-Juan Bao

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in BioData Mining
Verified
Journal Article
Open access
PDF file
WJWei Jiang
Wei Jiang
WYWeicai Ye
Weicai Ye
XTXiaoming Tan
Xiaoming Tan
YBYun-Juan Bao
Yun-Juan Bao
The integration of multi-omics data from diverse high-throughput technologies has revolutionized drug discovery. While various network-based methods have been developed to integrate multi-omics data, systematic evaluation and comparison of these methods remain challenging. This review aims to analyze network-based approaches for multi-omics integration and evaluate their applications in drug discovery. We conducted a comprehensive review of literature (2015–2024) on network-based multi-omics integration methods in drug discovery, and categorized methods into four primary types: network propagation/diffusion, similarity-based approaches, graph neural networks, and network inference models. We also discussed the applications of the methods in three scenario of drug discovery, including drug target identification, drug response prediction, and drug repurposing, and finally evaluated the performance of the methods by highlighting their advantages and limitations in specific applications. While network-based multi-omics integration has shown promise in drug discovery, challenges remain in computational scalability, data integration, and biological interpretation. Future developments should focus on incorporating temporal and spatial dynamics, improving model interpretability, and establishing standardized evaluation frameworks.

12 April 2021 in Viruses
Verified
Journal Article
Open access
PDF file
MFMadiha Fatima
Madiha Fatima
YLYuzi Luo
Yuzi Luo
LZLi Zhang
Li Zhang
PWPeng-Ying Wang
Peng-Ying Wang
HSHao Song
Hao Song
Hua-Ji QiuHua-Ji Qiu
Hua-Ji Qiu
Classical swine fever (CSF) is a highly contagious disease of swine caused by classical swine fever virus (CSFV). For decades the disease has been controlled in China by a modified live vaccine (C-strain) of genotype 1. The emergent genotype 2 strains have become predominant in China in the past years that are genetically distant from the vaccine strain. Here, we aimed to evaluate the current infectious status of CSF, and for this purpose 24 isolates of CSFV were identified from different areas of China during 2016–2018. Phylogenetic analysis of NS5B, E2 and full genome revealed that the new isolates were clustered into subgenotype 2.1d and 2.1b, while subgenotype 2.1d was predominant. Moreover, E2 and Erns displayed multiple variations in neutralizing epitope regions. Furthermore, the new isolates exhibited capacity to escape C-strain-derived antibody neutralization compared with the Shimen strain (genotype 1). Potential positive selection sites were identified in antigenic regions of E2 and Erns, which are related with antibody binding affinity. Recombination events were predicted in the new isolates with vaccine strains in the E2 gene region. In conclusion, the new isolates showed molecular variations and antigenic alterations, which provide evidence for the emergence of vaccine-escaping mutants and emphasize the need of updated strategies for CSF control.

9 March 2021 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
YBYun-Juan Bao
Yun-Juan Bao
JQJunhui Qiu
Junhui Qiu
YLYuzi Luo
Yuzi Luo
Fernando RodriguezFernando Rodriguez
Fernando Rodriguez
Hua-Ji QiuHua-Ji Qiu
Hua-Ji Qiu

20 January 2023 in Journal of Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
YBYun-Juan Bao
Yun-Juan Bao
QZQi Zhou
Qi Zhou
XYXuejing Yu
Xuejing Yu
XYXiaolan Yu
Xiaolan Yu
FCFrancis J. Castellino
Francis J. Castellino
Yun-Juan Bao, Qi Zhou, Xuejing Yu, Xiaolan Yu, and Francis J. Castellino. J. Microbiol. Biotechnol. 2023;33:299-309. https://doi.org/10.4014/jmb.2209.09006

12 February 2024 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
QZQi Zhou
Qi Zhou
WYWeicai Ye
Weicai Ye
XYXiaolan Yu
Xiaolan Yu
YBYun-Juan Bao
Yun-Juan Bao

6 December 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
WJWei Jiang
Wei Jiang
PWPeng-Ying Wang
Peng-Ying Wang
QZQi Zhou
Qi Zhou
QLQiu-Tong Lin
Qiu-Tong Lin
YYYao Yao
Yao Yao
YBYun-Juan Bao
Yun-Juan Bao
Background: With the development of cancer precision medicine, a huge amount of high-dimensional cancer information has rapidly accumulated regarding gene alterations, diseases, therapeutic interventions and various annotations. The information is highly fragmented across multiple different sources, making it highly challenging to effectively utilize and exchange the information. Therefore, it is essential to create a resource platform containing well-aggregated, carefully mined, and easily accessible data for effective knowledge sharing. Methods: In this study, we have developed “Consensus Cancer Core” (Tri©DB), a new integrative cancer precision medicine knowledgebase and reporting system by mining and harmonizing multifaceted cancer data sources, and presenting them in a centralized platform with enhanced functionalities for accessibility, annotation and analysis. Results: The knowledgebase provides the currently most comprehensive information on cancer precision medicine covering more than 40 annotation entities, many of which are novel and have never been explored previously. Tri©DB offers several unique features: (i) harmonizing the cancer-related information from more than 30 data sources into one integrative platform for easy access; (ii) utilizing a variety of data analysis and graphical tools for enhanced user interaction with the high-dimensional data; (iii) containing a newly developed reporting system for automated annotation and therapy matching for external patient genomic data. Benchmark test indicated that Tri©DB is able to annotate 46% more treatments than two officially recognized resources, oncoKB and MCG. Tri©DB was further shown to have achieved 94.9% concordance with administered treatments in a real clinical trial. Conclusions: The novel features and rich functionalities of the new platform will facilitate full access to cancer precision medicine data in one single platform and accommodate the needs of a broad range of researchers not only in translational medicine, but also in basic biomedical research. We believe that it will help to promote knowledge sharing in cancer precision medicine. Tri©DB is freely available at www.biomeddb.org, and is hosted on a cutting-edge technology architecture supporting all major browsers and mobile handsets.